cobas liat SARS-CoV-2, Influenza A/B & RSV
Classification
- Category
- Molecular Assays
- Product Type
- Assay Kit
- Technology
- RT-PCR
Application
- Application Area
- Respiratory
- Target Pathogens
- SARS-CoV-2, Influenza, RSV
Workflow
- Sample Types
- Np Swab
- Turnaround Time
- approximately 20 minutes
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
EUA The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test is an automated rapid multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the simultaneous qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus, influenza B virus and respiratory syncytial virus (RSV) RNA in…
The organism(s) detected by the cobas liat SARS- CoV-2, Influenza A/B & RSV nucleic acid test may not be the definite cause of disease.
The cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test is intended for use by trained operators specifically instructed in the use of the cobas liat system and the cobas liat SARS-CoV-2, Influenza A/B & RSV nucleic acid test.
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-16
2026-11-02
availability varies